149 related articles for article (PubMed ID: 1420823)
1. Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation.
Asakura H; Hifumi S; Jokaji H; Saito M; Kumabashiri I; Uotani C; Morishita E; Yamazaki M; Shibata K; Mizuhashi K
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):469-73. PubMed ID: 1420823
[TBL] [Abstract][Full Text] [Related]
2. Hypercoagulability and chronic atrial fibrillation: the role of markers of thrombin generation.
Soncini M; Casazza F; Mattioli R; Bonfardeci C; Motta A; Cimminiello C
Minerva Med; 1997 Dec; 88(12):501-5. PubMed ID: 9540779
[TBL] [Abstract][Full Text] [Related]
3. Relationship between control of ventricular rate in atrial fibrillation and systemic coagulation activation in patients with mitral stenosis.
Atak R; Turhan H; Senen K; Yalta K; Ayaz S; Alyan O; Basar N; Demirkan D
J Heart Valve Dis; 2004 Mar; 13(2):159-64. PubMed ID: 15086252
[TBL] [Abstract][Full Text] [Related]
4. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
Koefoed BG; Feddersen C; Gulløv AL; Petersen P
Thromb Haemost; 1997 May; 77(5):845-8. PubMed ID: 9184390
[TBL] [Abstract][Full Text] [Related]
5. Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction.
Akar JG; Jeske W; Wilber DJ
J Am Coll Cardiol; 2008 May; 51(18):1790-3. PubMed ID: 18452786
[TBL] [Abstract][Full Text] [Related]
6. Prothrombin activation fragment 1 + 2 and thrombin-antithrombin-III complexes in plasma of patients with essential arterial hypertension.
Kłoczko J; Wojtukiewicz MZ; Galar M; Tarasów E; Jaromin J; Bielawiec M
Pol J Pharmacol; 1996; 48(2):233-5. PubMed ID: 9112658
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the prethrombotic state in pregnancy and in women using oral contraceptives.
Levine AB; Teppa J; McGough B; Cowchock FS
Contraception; 1996 May; 53(5):255-7. PubMed ID: 8724613
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis.
Kienast J; Thompson SG; Raskino C; Pelzer H; Fechtrup C; Ostermann H; van de Loo J
Thromb Haemost; 1993 Oct; 70(4):550-3. PubMed ID: 8115978
[TBL] [Abstract][Full Text] [Related]
9. Measurement of markers of activated coagulation in antithrombin III deficient subjects.
Demers C; Ginsberg JS; Henderson P; Ofosu FA; Weitz JI; Blajchman MA
Thromb Haemost; 1992 May; 67(5):542-4. PubMed ID: 1519214
[TBL] [Abstract][Full Text] [Related]
10. [Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study].
Enta K; Iwade K; Aosaki M; Uchida T; Kasanuki H
J Cardiol; 2004 Dec; 44(6):223-32. PubMed ID: 15638220
[TBL] [Abstract][Full Text] [Related]
11. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
[TBL] [Abstract][Full Text] [Related]
12. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
[TBL] [Abstract][Full Text] [Related]
13. Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease--a preliminary study.
Iversen LH; Okholm M; Thorlacius-Ussing O
Thromb Haemost; 1996 Oct; 76(4):523-8. PubMed ID: 8902990
[TBL] [Abstract][Full Text] [Related]
14. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
Glazer NL; Dublin S; Smith NL; French B; Jackson LA; Hrachovec JB; Siscovick DS; Psaty BM; Heckbert SR
Arch Intern Med; 2007 Feb; 167(3):246-52. PubMed ID: 17296879
[TBL] [Abstract][Full Text] [Related]
15. Different effects of enoxaparin and unfractionated heparin on some thrombogenesis markers during hemodialysis: a cross-over study.
Naumnik B; Pawlak K; Myśliwiec M
Thromb Res; 2009 Feb; 123(4):631-6. PubMed ID: 18234290
[TBL] [Abstract][Full Text] [Related]
16. An abnormal systemic and regional hypercoagulable state in patients with mitral stenosis.
Phankingthongkum R; Opartkiattikul N; Chotinaiwattarakul C; Panchavinnin P; Tresukosol D; Jakrapanichakul D; Krittayaphong R; Kitrattana B; Thongtang V
J Med Assoc Thai; 2004 Feb; 87(2):158-65. PubMed ID: 15061299
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
[TBL] [Abstract][Full Text] [Related]
18. Influence of atrial fibrillation on coagulo-fibrinolytic markers in patients with cerebral infarction.
Ono N; Koyama T; Suehiro A; Oku K; Fujikake K; Kakishita E
Int Angiol; 1992; 11(4):298-303. PubMed ID: 1284251
[TBL] [Abstract][Full Text] [Related]
19. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
20. Markers of hemostatic system activation in pulmonary embolism. Changes during and after cessation of anticoagulant treatment.
de Raucourt E; Meyer G; Landais P; Gouaref Z; Morinet P; Monge F; Sors H; Fischer AM
Blood Coagul Fibrinolysis; 2000 Apr; 11(3):249-53. PubMed ID: 10870805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
